NCT00022282View on ClinicalTrials.gov

AE-941 in Treating Patients With Relapsed or Refractory Multiple Myeloma

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

April 30, 2001

Primary Completion Date

March 31, 2007

Conditions
Multiple Myeloma and Plasma Cell Neoplasm
Interventions
DRUG

shark cartilage extract AE-941

Trial Locations (1)

Unknown

Québec

Sponsors

Lead Sponsor

AEterna Zentaris
All Listed Sponsors
lead

AEterna Zentaris

INDUSTRY